Myomo stock.

A high-level overview of Myomo, Inc. (MYO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Myomo stock. Things To Know About Myomo stock.

Myomo, Inc. (NYSE:NYSE:MYO) Q4 2023 Earnings Conference Call March 7, 2024 4:30 PM ETCompany ParticipantsKim Golodetz - Investor Relations, LHAPaul Gudonis...Dec 18, 2023 · Myomo's market capitalization of $137.35M, combined with a high stock momentum (+766.22% over a year vs SPY's +21.14%), suggests strong market confidence. Data by YCharts According to the issued ratings of 2 analysts in the last year, the consensus rating for Myomo stock is Buy based on the current 2 buy ratings for MYO. The average twelve-month price prediction for Myomo is $6.50 with a high price target of $6.50 and a low price target of $6.50. Learn more on MYO's analyst rating history.Stock Price Forecast. The 2 analysts with 12-month price forecasts for Myomo stock have an average target of 4.25, with a low estimate of 2.00 and a high estimate of 6.50. The average target predicts an increase of 13.03% from the current stock price of 3.76. Jan-17-24 08:05AM. Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market. (Business Wire) +7.89%. 08:00AM. Myomo Reports Preliminary Fourth Quarter Revenue and Backlog. (Business Wire) Dec-20-23 08:50AM. What Makes Myomo, Inc. (MYO) a Good Fit for 'Trend Investing'.

Myomo Company Info. Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. It offers MyoPro, an upper-limb ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.MYO Myomo, Inc. Latest News. Follow. 5.04K followers. $3.64 -0.19 ( -4.96%) 3:59 PM 05/13/24. NYSE | $USD | Post-Market: $3.64 8:00 PM. Summary. Ratings. …

Find the latest Myomo, Inc. (MYO) stock quote, history, news and other vital information to help you with your stock trading and investing.Find out all the key statistics for Myomo, Inc. (MYO), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta (5Y ...17 Sept 2020 ... Only 3.6 million Outstanding Shares. Next big catalyst will be Q3 ER in early November and even without Medicare/Medicaid approval they were ...Myomo, Inc. (NYSE:NYSE:MYO) Q4 2023 Earnings Conference Call March 7, 2024 4:30 PM ETCompany ParticipantsKim Golodetz - Investor Relations, LHAPaul Gudonis...

En direct tva

Myomo Inc. Common Stock (MYO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market 01-17 - 2 views Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations Q3 total revenue of $5.1 million, up 28% over the prior year 156 MyoPro orders and insurance authorizations received, including the ...Dec 18, 2023 · Myomo's market capitalization of $137.35M, combined with a high stock momentum (+766.22% over a year vs SPY's +21.14%), suggests strong market confidence. Data by YCharts 7 Mar 2024 ... Adjusted EBITDA is EBITDA adjusted for stock-based compensation expense and loss on equity investment. This non-GAAP financial measure is ...Myomo stock is down after pricing a public stock offering. The offering includes 7,333,334 shares sold at 60 cents each. This has gross proceeds coming in at $4.4 million.See the company profile for Myomo, Inc. (MYO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...

The latest closing stock price for Myomo as of May 06, 2024 is 3.94. The all-time high Myomo stock closing price was 579.30 on June 19, 2017. The Myomo 52-week high stock price is 5.58, which is 41.6% above the current share price. The Myomo 52-week low stock price is 0.37, which is 90.6% below the current share price.BOSTON, February 29, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from ...View Myomo, Inc. MYO stock quote prices, financial information, real-time forecasts, and company news from CNN. ... Myomo, Inc. is a wearable medical robotics company, which engages in the ...Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market. BOSTON, January 19, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a ...May 8, 2024 · What is Myomo's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for Myomo stock is Buy based on the current 2 buy ratings for MYO. The average twelve-month price prediction for Myomo is $6.50 with a high price target of $6.50 and a low price target of $6.50. Get the latest Myomo Inc (MYO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Access our live streaming chart for the Myomo Inc Share, free of charge.

Real-time Price Updates for Myomo Inc (MYO-A), along with buy or sell indicators, analysis, charts, historical performance, news and more

The MyoPro Brace for Stroke Survivor's Paralyzed Arm. MyoPro is a powered arm and hand orthosis (brace) designed to help restore function to the wearer’s paralyzed or weakened upper extremities, helping individuals perform actions and daily activities that might otherwise be impossible. The MyoPro may also facilitate rehabilitation including ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestig... Myomo, Inc. (MYO) NYSE American - Nasdaq Real-time price. Currency in USD. As of 10:19AM EDT. Market open. Find the latest Myomo, Inc. (MYO) stock quote, history, news and other vital information to help you with your stock trading and investing. A high-level overview of Myomo, Inc. (MYO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.What is Myomo's consensus rating and price target? According to the issued ratings of 2 analysts in the last year, the consensus rating for Myomo stock is Buy based on the current 2 buy ratings for MYO. The average twelve-month price prediction for Myomo is $6.50 with a high price target of $6.50 and a low price target of $6.50.View MYO: Myomoinvestment & stock information. Get the latest MYO: Myomo detailed stock quotes, stock data, Real-Time ECN, charts, stats and more..Jan. 17. MT. Myomo, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023. Jan. 17. CI. Certain Warrants of Myomo, Inc. are subject to a Lock-Up Agreement Ending on 29-NOV-2023. Nov. 28. CI. Myomo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023.Get the latest Myomo Inc (MYO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Jan. 17. CI. Certain Warrants of Myomo, Inc. are subject to a Lock-Up Agreement Ending on 29-NOV-2023. Nov. 28. CI. Myomo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023. Nov. 07. CI. Earnings Flash (MYO) MYOMO Posts Q3 Revenue $5.1M, vs. Street Est of $4.2M.

Lbc trace tracking

Real-time Price Updates for Myomo Inc (MYO-A), along with buy or sell indicators, analysis, charts, historical performance, news and more

BOSTON, January 17, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological ...MYO's current price target is $6.50. Learn why top analysts are making this stock forecast for Myomo at MarketBeat. Jan. 17. CI. Certain Warrants of Myomo, Inc. are subject to a Lock-Up Agreement Ending on 29-NOV-2023. Nov. 28. CI. Myomo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023. Nov. 07. CI. Earnings Flash (MYO) MYOMO Posts Q3 Revenue $5.1M, vs. Street Est of $4.2M. ... Myomo. This agreement includes nearly 1.6 million shares of common stock priced at $3.80 per share. In conjunction with the offering, Myomo disclosed that ...BOSTON, January 17, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological ...How much is Myomo stock worth today? ( NYSEMKT: MYO) Myomo currently has 28,487,168 outstanding shares. With Myomo stock trading at $3.43 per share, the total value of Myomo stock (market capitalization) is $97.71M. Myomo stock was originally listed at a price of $222.00 in Jun 12, 2017.Stock analysis for Myomo Inc (MYO:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Myomo Inc. is an attractive microcap company from a long-term investment standpoint. The recent patent approvals in China and Hong Kong only strengthen the long-term outlook. ... The stock is ...Myomo stock is down after pricing a public stock offering. The offering includes 7,333,334 shares sold at 60 cents each. This has gross proceeds coming in at $4.4 million.

Complete Myomo Inc. stock information by Barron's. View real-time MYO stock price and news, along with industry-best analysis. Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the pricing of its "best efforts" public offering of 20,000,000 shares of common stock (or common stock … Complete Myomo Inc. stock information by Barron's. View real-time MYO stock price and news, along with industry-best analysis. Jan. 17. CI. Certain Warrants of Myomo, Inc. are subject to a Lock-Up Agreement Ending on 29-NOV-2023. Nov. 28. CI. Myomo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023. Nov. 07. CI. Earnings Flash (MYO) MYOMO Posts Q3 Revenue $5.1M, vs. Street Est of $4.2M.Instagram:https://instagram. mdt mt View the real-time Myomo Inc (NYSE MYO) share price. Assess historical data, charts, technical analysis and contribute in the forum. map of wisconsin usa Dec 20, 2023 · Myomo, Inc. (MYO) is one of the several suitable candidates that passed through the screen. Here are the key reasons why it could be a profitable bet for "trend" investors. Myomo Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time MYO stock price. jeremiah johnson film BOSTON, May 08, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological ... moe southwest Myomo, Inc. (MYO) delivered earnings and revenue surprises of 25.81% and 51.86%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?Find the latest analyst research for Myomo Inc. Common Stock (MYO) at Nasdaq.com. msp to newark Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market. BOSTON, January 19, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a ...Myomo’s common stock will continue to trade on the NYSE American under the symbol “MYO,” although a new CUSIP number (62857J 201) has been assigned to it as a result of the reverse stock split. stream tbs free Myomo ( NYSEMKT: MYO) is owned by 33.21% institutional shareholders, 11.64% Myomo insiders, and 55.15% retail investors. Paul R. Gudonis is the largest individual Myomo shareholder, owning 878,245.00 shares representing 3.08% of the company. Paul R. Gudonis's Myomo shares are currently valued at $3.01M. If you're new to stock investing, here's . capital one account summary 7 Mar 2024 ... Adjusted EBITDA is EBITDA adjusted for stock-based compensation expense and loss on equity investment. This non-GAAP financial measure is ... Medical Products Manufacturing. $0.110B. $0.019B. Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro (R) product line of lightweight, non-invasive, powered arm braces to restore function in the ... About Us. Based on patented technology developed at MIT, Harvard Medical School and by the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces (orthoses) to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve ... where to watch detachment View the latest Myomo Inc. (MYO) stock price, news, historical charts, analyst ratings and financial information from WSJ. dc to phoenix What is Myomo's stock price target for 2024? 2 brokerages have issued 1-year price targets for Myomo's stock. Their MYO share price targets range from $6.50 to $6.50. On average, they expect the company's share price to reach $6.50 in the next year. This suggests a possible upside of 70.6% from the stock's current price. boston to california © 2024 Myomo Inc. - All rights reserved. Made in the USA. Myomo, Inc. is the owner of registered trademarks Myomo and MyoPro. Terms Of Use & Privacy Policy.Myomo, Inc. (MYO) delivered earnings and revenue surprises of 25.81% and 51.86%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock? alone the film Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2024.. Total and product revenue was $3.8 million, up 9%; Revenue units were 91, up 14%; MyoPro ® orders and …CAMBRIDGE, Mass., February 8, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the pricing of its previously announced underwritten public offering of 3,950,000 shares of its common stock at an offering ...Myomo, Inc. (NYSE:MYO) is considered one of the best robotic stocks under $10 due to improving business fundamentals. During Q3, the company experienced exceptional growth, with 419 patients ...